pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: Intravenous Acetaminophen/Ibuprofen Fixed-dose Combination on Postoperative Opioid Consumption
Status: COMPLETED
Conditions: Postoperative Pain
Interventions: DRUG: acetaminophen/ibuprofen fixed-dose combination|DRUG: Saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Impact GLP-1 Agonists Following Bariatric
Status: RECRUITING
Conditions: Morbid Obesity|Metabolic Syndrome|Diabetes Mellitus|Hypertension|Obstructive Sleep Apnea of Adult
Interventions: DRUG: GLP-1 receptor agonist
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Phase 2 Study Of PF-00232798 In HIV Positive Patients
Status: COMPLETED
Conditions: HIV
Interventions: DRUG: PF-00232798|DRUG: PF-00232798|DRUG: PF-00232798|DRUG: PF-00232798|DRUG: PF-00232798|DRUG: PF-00232798
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Benefits of Traditional and Golf-specific Resistance Training in Amateur Female Golfers
Status: COMPLETED
Conditions: Improved Performance in Amateur Female Golfers (MESH Term: Body Composition)
Interventions: OTHER: Traditional strengthening|OTHER: Functional Strengthening
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Impact of a Telephone Coaching Program on Evolution of Autonomy in Subjects Aged 75 Years or More Living at Home
Status: COMPLETED
Conditions: Subjects Aged 75 Years or More Living at Home
Interventions: OTHER: telephone coaching program|OTHER: no telephone coaching program
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Evaluate the Pharmacokinetics, Safety and Tolerability of JT001 Tablets
Status: WITHDRAWN
Conditions: Healthy Subjects
Interventions: DRUG: JT001 200mg Bid|DRUG: JT001 400mg Bid|DRUG: JT001 600mg Bid
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Belimumab Assessment of Safety in SLE
Status: COMPLETED
Conditions: Systemic Lupus Erythematosus
Interventions: BIOLOGICAL: Placebo plus standard therapy|BIOLOGICAL: Belimumab 10 mg/kg plus standard therapy|OTHER: Standard therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Hepatitis A Vaccine Dosing Regimens Among Pediatric Patients on Immunosuppressive Therapy
Status: COMPLETED
Conditions: Autoimmune Rheumatologic Disease
Interventions: BIOLOGICAL: Avaxim Pediatric®|BIOLOGICAL: Avaxim ® (adult)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Glioblastoma Multiforme
Status: COMPLETED
Conditions: Brain and Central Nervous System Tumors
Interventions: DRUG: temozolomide|GENETIC: DNA methylation analysis|PROCEDURE: quality-of-life assessment|RADIATION: Radiation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Pilot Study: Snacking, Willpower and Glucose Availability
Status: COMPLETED
Conditions: Willpower
Interventions: DIETARY_SUPPLEMENT: Sequence 1|DIETARY_SUPPLEMENT: Sequence 2|DIETARY_SUPPLEMENT: Sequence 3|DIETARY_SUPPLEMENT: Sequence 4
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose:
Clinical trial: Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older
Status: COMPLETED
Conditions: Herpes Zoster
Interventions: BIOLOGICAL: Herpes Zoster Vaccine GSK1437173A|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Efficacy of Opioid-free Anesthesia in Reducing Postoperative Pain in Chronic Pain Patients Undergoing Spinal Surgery
Status: UNKNOWN
Conditions: Chronic Pain|Anesthesia
Interventions: DRUG: Opioid-free general anesthetic|DRUG: Traditional general anesthetic
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects
Status: COMPLETED
Conditions: Overactive Bladder
Interventions: COMBINATION_PRODUCT: ViXe Xombination|COMBINATION_PRODUCT: Placebo + Sham
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Aerosolized Endotracheal Lidocaine to Avoid Intracranial Pressure Spikes in Patients With Severe Traumatic Brain Injury
Status: RECRUITING
Conditions: Traumatic Brain Injury
Interventions: DRUG: aerosolized 2% lidocaine (20mg/ml)|DRUG: instilled 0.9% sodium chloride (NS)|DRUG: instilled 2% lidocaine solution|PROCEDURE: Endotracheal Suctioning (ETS)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Deep Brain Stimulation of NAc/ALIC to Prevent Treatment-Refractory Obsessive Compulsive Disorder
Status: UNKNOWN
Conditions: Obsessive Compulsive Disorder
Interventions: PROCEDURE: Deep brain stimulation|DRUG: Fluoxetine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: OC000459 Dose Finding Study in Patients With Mild to Moderate Persistent Asthma
Status: COMPLETED
Conditions: Mild to Moderate Persistent Asthma
Interventions: DRUG: OC000459 or placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of Topical Calcipotriene/Betamethasone (Taclonex) in Managing Localized Breakthrough in Moderate to Severe Plaque Psoriasis in Patients Receiving Efalizumab (Raptiva)
Status: TERMINATED
Conditions: Plaque Psoriasis
Interventions: DRUG: Calcipotriene/betamethasone
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effects of Motor Imagery and Action Observation Training on Pain Perception in Patients With Chronic Neck Pain
Status: COMPLETED
Conditions: Pain, Chronic
Interventions: BEHAVIORAL: Action Observation|BEHAVIORAL: Motor imagery|BEHAVIORAL: Placebo Action observation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of Varenicline for Prevention of Relapse to Smoking in Patients With Schizophrenia or Bipolar Disorder
Status: COMPLETED
Conditions: Schizophrenia|Schizoaffective Disorder|Bipolar Disorder|Smoking
Interventions: DRUG: Varenicline|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The GATE Study: Endoscopic Sutured Gastroplasty in Type 2 Diabetic, Obese Patients Using the Endomina Device
Status: NOT_YET_RECRUITING
Conditions: Diabete Type 2|Obesity
Interventions: DEVICE: Endoscopic sutured gastroplasty with endomina
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Prospective Study to Compare Bupivacaine and Exparel Versus Bupivacaine or Exparel Alone for Postoperative Pain Relief
Status: TERMINATED
Conditions: Low Back Pain|Lumbosacral Radiculopathy|Lumbar Disc Degeneration|Lumbar Disc Herniation|Stenosis|Spondylolisthesis|Spondylolysis|Deformity of Spine
Interventions: DRUG: Exparel|DRUG: Bupivacaine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, CARE_PROVIDER)|Primary Purpose: BASIC_SCIENCE
Clinical trial: A Multicenter, Multinational, Observational Morquio A Registry Study (MARS)
Status: COMPLETED
Conditions: Mucopolysaccharidosis IV Type A|Morquio A Syndrome|MPS IVA
Interventions: DRUG: Vimizim® (elosulfase alfa)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Study to Evaluate Efficacy and Tolerance of R-GemOx in DLBCL and MCL
Status: COMPLETED
Conditions: Aggressive Lymphoma|Diffuse Large B-cell Lymphoma|Mantle Cell Lymphoma
Interventions: DRUG: Rituximab, Gemcitabine, Oxaliplatin, Dexametasone
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Participants With Chronic Hepatitis C Virus Infection Without Cirrhosis
Status: COMPLETED
Conditions: Hepatitis C Virus Infection
Interventions: DRUG: Simeprevir|DRUG: Simeprevir|DRUG: Sofosbuvir|DRUG: Sofosbuvir
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Pain Neuroscience Education vs Biomedical Education for Patients Undergoing Surgery for Shoulder Pain
Status: UNKNOWN
Conditions: Shoulder Pain
Interventions: OTHER: Pain Neuroscience education|OTHER: Biomedical Education
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Immunogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Previously Boosted Young Adults
Status: COMPLETED
Conditions: Tetanus|Acellular Pertussis|Diphtheria
Interventions: BIOLOGICAL: Boostrix
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Propofol Administered by Gastroenterologists by Target Controlled Infusion Pump During Endoscopy
Status: COMPLETED
Conditions: Sedation|Endoscopy
Interventions: DRUG: Propofol|DRUG: Midazolam
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Study of GM-XANTHO in Pressure Ulcer Patients
Status: NOT_YET_RECRUITING
Conditions: Pressure Ulcer|Diabetes Mellitus
Interventions: DRUG: GM-XANTHO
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Bendamustine/Lenalidomide/Rituximab: Combination as a Second-Line Therapy for 1st Relapsed-Refractory MCL
Status: COMPLETED
Conditions: Mantle Cell Lymphoma
Interventions: DRUG: Bendamustine, Lenalidomide, Rituximab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients
Status: NOT_YET_RECRUITING
Conditions: Hypertension
Interventions: OTHER: educational intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: Cardiac Output Monitoring to Predict Pre-Eclampsia and Restricted Growth (COMPaRE)
Status: UNKNOWN
Conditions: Fetal Growth Retardation|Pre-Eclampsia
Interventions: DIAGNOSTIC_TEST: Non-invasive haemodynamic assessment|DIAGNOSTIC_TEST: Maternal ophthalmic artery doppler
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy
Status: COMPLETED
Conditions: Schizophrenia
Interventions: DRUG: Risperidone|DRUG: RBP-7000
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness and Safety of 3 Fixed Doses (25 mg eq., 100 mg eq., and 150 mg eq.) of Paliperidone Palmitate in Patients With Schizophrenia
Status: COMPLETED
Conditions: Schizophrenia
Interventions: DRUG: Paliperidone palmitate 25 mg eq.|DRUG: Paliperidone palmitate 150 mg eq.|DRUG: Placebo|DRUG: Paliperidone palmitate 100 mg eq.
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Polatuzumab Vedotin and Combination Chemotherapy for the Treatment of Untreated Aggressive Large B-cell Lymphoma
Status: RECRUITING
Conditions: Aggressive Non-Hodgkin Lymphoma|ALK-Positive Large B-Cell Lymphoma|B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classic Hodgkin Lymphoma|Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|EBV-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified|High Grade B-Cell Lymphoma With MYC and BCL2 and/or BCL6 Rearrangements|High Grade B-Cell Lymphoma, Not Otherwise Specified|Primary Mediastinal (Thymic) Large B-Cell Lymphoma|T-Cell/Histiocyte-Rich Large B-Cell Lymphoma
Interventions: DRUG: Polatuzumab Vedotin|BIOLOGICAL: Rituximab|DRUG: Prednisone|DRUG: Etoposide|DRUG: Doxorubicin|DRUG: Cyclophosphamide|BIOLOGICAL: Filgrastim
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Factors Influencing Breast Cancer Resection Volumes And Their Impact on Treatment Outcome (FIBRATIO)
Status: ACTIVE_NOT_RECRUITING
Conditions: Breast Cancer|Quality of Life|Patient Satisfaction|Resection Margin|Surgical Margin|Multidisciplinary Communication
Interventions: PROCEDURE: Breast conserving surgery
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Electrical Muscle Stimulation on Muscle Stiffness and Functional Capacity in Post-menopausal Women
Status: ACTIVE_NOT_RECRUITING
Conditions: Electric Stimulation Therapy|Frailty|Women
Interventions: OTHER: High-frequency electrical muscle stimulation training|OTHER: Low-frequency electrical muscle stimulation training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: STEPWISE Parkinson: A Smartphone Based Exercise Solution for Patients With Parkinson's Disease
Status: RECRUITING
Conditions: Movement Disorders|Parkinson Disease
Interventions: BEHAVIORAL: Step count increase with the use of a motivational smartphone application
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: To Evaluate the Efficacy and Safety of SR419 in Patients With Postherpetic Neuralgia (PHN)
Status: COMPLETED
Conditions: Postherpetic Neuralgia
Interventions: DRUG: SR419
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Perinatal Attentional Retraining Intervention for Smoking for Minority Women
Status: COMPLETED
Conditions: Postpartum Smoking Relapse
Interventions: BEHAVIORAL: Attentional retraining (AR)|BEHAVIORAL: Visual probe (VP)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: A Placebo-controlled Study to Investigate Safety and Efficacy of BIA 2-093
Status: COMPLETED
Conditions: Epilepsy
Interventions: DRUG: BIA 2-093|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effect of LIA on Postoperative Pain Following ACL Reconstruction
Status: UNKNOWN
Conditions: Anterior Cruciate Ligament Rupture|Pain, Postoperative
Interventions: PROCEDURE: local infiltration analgesia
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Thin-Flap Laser in Situ Keratomileusis Associated Dry Eye
Status: COMPLETED
Conditions: Myopic LASIK Candidates With Spherical Equivalent up to - 10 Diopters
Interventions: PROCEDURE: Laser in situ keratomileusis
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Compare Bioavailability of AZD5055 Film-coated Tablet With AZD5055 Oral Suspension and to Assess the Effect of Food and an Acid Reducing Agent on Pharmacokinetics (PK) of AZD5055 in Healthy Subjects.
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: AZD5055 solution for infusion|DRUG: AZD5055 oral suspension|DRUG: AZD5055 film-coated tablet|DRUG: AZD5055 film-coated tablet|DRUG: Rabeprazole, Delayed-release tablet|DRUG: Rabeprazole, Delayed-release tablet
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer
Status: COMPLETED
Conditions: Ovarian Cancer
Interventions: DRUG: Topotecan|DRUG: Topotecan
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Opioid Induced Swallowing Difficulties and Risk for Pulmonary Aspiration
Status: COMPLETED
Conditions: Opioid Induced Swallowing Disorders
Interventions: DRUG: Remifentanil|DRUG: Placebo|DRUG: Technetium|DEVICE: Dynamometer (Jamar)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Propofol Versus Dexmedetomidine on the Incidence of Postoperative Nausea and Vomiting
Status: RECRUITING
Conditions: Nausea and Vomiting, Postoperative
Interventions: DRUG: Dexmedetomidine|DRUG: Propofol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Take-home Functional Electrical Stimulation for MDD
Status: ACTIVE_NOT_RECRUITING
Conditions: MDD
Interventions: DEVICE: Functional Electrical Stimulation (FES)|DEVICE: Sham FES
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: CP-690,550 Thorough QTc Study
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: CP-690,550|DRUG: Placebo|DRUG: Moxifloxacin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts
Status: COMPLETED
Conditions: Influenza|Infections, Pneumococcal
Interventions: OTHER: Arm 1: E-portal message with IVR call|OTHER: Arm 2: E-portal message with no IVR call|OTHER: Arm 3: No e-portal message with IVR call|OTHER: Arm 5: IVR call
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Optimization of Saturation Targets And Resuscitation Trial (OptiSTART)
Status: RECRUITING
Conditions: Premature Infants|Bronchopulmonary Dysplasia|Intraventricular Hemorrhage|Neurodevelopmental Outcomes
Interventions: OTHER: Sat75|OTHER: Sat50
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Morphine vs. Oxycodone for Postoperative Pain Management
Status: COMPLETED
Conditions: Hysterectomy|Myoma|Postoperative Pain|Opioids
Interventions: DRUG: Morphine and oxycodone
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Evaluation of Lactobacillus Fermentum CECT5716 on the Incidence of Mastitis
Status: COMPLETED
Conditions: Mastitis
Interventions: DIETARY_SUPPLEMENT: Lactobacillus fermentum CECT5716|DIETARY_SUPPLEMENT: Maltodextrin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer
Status: COMPLETED
Conditions: Gastric Cancer
Interventions: BIOLOGICAL: URLC10, KOC1, VEGFR1 and VEGFR2
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Influenza Vaccination in Fibromyalgia Patients
Status: UNKNOWN
Conditions: Fibromyalgia Syndrome
Interventions: BIOLOGICAL: Inactivated split virion Influenza vaccine|BIOLOGICAL: WHO recommended 2011 Influenza vacccine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy in Controlling Glycaemia With Victoza® (Liraglutide) as add-on to Metformin vs. OADs as add-on to Metformin After up to 104 Weeks of Treatment in Subjects With Type 2 Diabetes
Status: COMPLETED
Conditions: Diabetes|Diabetes Mellitus, Type 2
Interventions: DRUG: liraglutide|DRUG: alpha-glucosidase inhibitors|DRUG: DPP-4 inhibitors|DRUG: meglitinides|DRUG: SGLT-2 inhibitors|DRUG: sulphonylurea|DRUG: thiazolidinediones
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Hypofractionation And Ultra-Hypofractionation In Adjuvant Radiotherapy For Breast Cancer
Status: UNKNOWN
Conditions: Breast Cancer
Interventions: RADIATION: Hypofractionation|RADIATION: ultraHypofractionation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: FOLFIRI and Panitumumab in Treating Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer
Status: TERMINATED
Conditions: Recurrent Colorectal Carcinoma|Stage IVA Colorectal Cancer|Stage IVB Colorectal Cancer
Interventions: DRUG: Fluorouracil|DRUG: Irinotecan Hydrochloride|OTHER: Laboratory Biomarker Analysis|DRUG: Leucovorin Calcium|BIOLOGICAL: Panitumumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: PhytoSERM to Prevent Menopause Associated Decline in Brain Metabolism and Cognition
Status: RECRUITING
Conditions: Menopause|Cognitive Change|Brain Disorder, Metabolic
Interventions: DIETARY_SUPPLEMENT: PhytoSERM|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mulligan Technique Versus McKenzie Extension Exercise Chronic Unilateral Radicular Low Back Pain
Status: COMPLETED
Conditions: Low Back Pain
Interventions: OTHER: Mulligan techniques with manual traction|OTHER: McKenzie extension exercises with manual traction
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: FMT for Moderate to Severe CDI: A Randomised Study With Concurrent Stool Microbiota Assessment
Status: ACTIVE_NOT_RECRUITING
Conditions: Clostridium Difficile Infection
Interventions: PROCEDURE: Fecal Microbiota Transplantation|DRUG: Vancomycin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: NEUROTOX: Two Dosages of Type A Botulinic Toxin in Neurogenic Overactive Bladder
Status: TERMINATED
Conditions: Overactive Bladder
Interventions: DRUG: type A botulinum toxin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Renal Function in Highly Sensitized Patients 1 Year After Desensitization With Imlifidase Prior to DD Kidney Tx
Status: ACTIVE_NOT_RECRUITING
Conditions: Kidney Transplantation in Highly Sensitized Patients
Interventions: DRUG: Imlifidase|PROCEDURE: PLEX|DRUG: IVIg|DRUG: Anti-CD20 antibodies|DRUG: Eculizumab|OTHER: Remain on wait list
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study of Xeloxiri Regimen for Patients With Refractory Metastatic Colorectal Cancer
Status: COMPLETED
Conditions: Colorectal Cancer
Interventions: DRUG: Capecitabine|DRUG: Oxaliplatin|DRUG: Irinotecan
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pharmacokinetic (PK) Study of Oral and IV TR-701 FA in Adolescent Patients
Status: COMPLETED
Conditions: Bacterial Infection
Interventions: DRUG: TR-701 FA|DRUG: TR-701 FA
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine
Status: RECRUITING
Conditions: Dravet Syndrome (DS)|Lennox-Gastaut Syndrome (LGS)
Interventions: DRUG: Soticlestat
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of YAM80 in Amyotrophic Lateral Sclerosis (ALS)
Status: UNKNOWN
Conditions: Amyotrophic Lateral Sclerosis
Interventions: DRUG: YAM80
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: TRIGR - Primary Prevention Study for Type 1 Diabetes in Children at Risk
Status: COMPLETED
Conditions: Diabetes Mellitus, Type 1
Interventions: DIETARY_SUPPLEMENT: Hydrolysed infant formula|DIETARY_SUPPLEMENT: Nonhydrolysed infant formula
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Double-blinded, Randomized, Placebo-controlled Study Evaluating the Effect of the Probiotic on Recurrent Urinary Tract Infection
Status: COMPLETED
Conditions: Recurrent Urinary Tract Infection in Adult Women
Interventions: DIETARY_SUPPLEMENT: Probiotic
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Psychoneuromentalism Disorder: A Medical Condition That Affects People With Psychological Impairments From Health Issues
Status: NOT_YET_RECRUITING
Conditions: Schizoaffective Disorder, Bipolar Type|Bipolar Disorder|ADHD - Combined Type|Dissociative Disorder|Stress Disorder|Dementia|Anxiety|Chronic Fatigue Syndrome
Interventions: COMBINATION_PRODUCT: Decompartmentalization Framework|DIETARY_SUPPLEMENT: Liquid Herbal TInctures|OTHER: Mental Imagery|DIAGNOSTIC_TEST: Clinical Yoga|DIETARY_SUPPLEMENT: Dietary Supplements|BEHAVIORAL: Applied Relaxation|BEHAVIORAL: Pain Relaxation Techniques|BEHAVIORAL: Comprehensive Theocentric Psychological Assessment
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Toward the Development of a Bronchoscope With a Dedicated O2 Channel ?
Status: COMPLETED
Conditions: Bronchoscopy|O2-supplementation
Interventions: DEVICE: O2 through nasal cannulae|DEVICE: O2-channel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: DIAGNOSTIC
Clinical trial: TAP Block On Abdominal Surgery Patients With General Anesthesia
Status: COMPLETED
Conditions: Post-Op Complication|Pain, Postoperative
Interventions: PROCEDURE: transversus abdominis plane (TAP) block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Safety and Efficacy of Mupirocin Gel in Children With Impetigo
Status: COMPLETED
Conditions: Impetigo
Interventions: DRUG: Mupirocin gel|DRUG: Mupirocin ointment|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Ribavirin in Adults With Genotype 1 and Ombitasvir/Paritaprevir/Ritonavir With Ribavirin in Adults With Genotype 4 Chronic Hepatitis C Virus Infection and Decompensated Cirrhosis
Status: COMPLETED
Conditions: Chronic Hepatitis C|Decompensated Cirrhosis|Hepatitis C Virus
Interventions: DRUG: ombitasvir/paritaprevir/ritonavir|DRUG: dasabuvir|DRUG: ribavirin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Pain Rehabilitation Virtual Reality (PRVR): Innovations to Enhance Mobility in the Presence of Pain
Status: ACTIVE_NOT_RECRUITING
Conditions: Chronic Pain|Musculoskeletal Pain|Fibromyalgia|Virtual Reality
Interventions: BEHAVIORAL: Pain Rehabilitation Virtual Reality (PRVR)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Relationship Between Prolonged Hospitalization and Surgical Experience in Pediatric Tonsillectomy Cases.
Status: COMPLETED
Conditions: Sleep Apnea|Tonsillitis Recurrent
Interventions: OTHER: PEDIATRIC TONSILLECTOMY; SURGICAL EXPERIENCE AND PROLONGED HOSPITALIZATION
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Effect of GM1 in Prevention of Oxaliplatin Induced Neurotoxicity in Stage II/III Colorectal Cancer
Status: COMPLETED
Conditions: Colorectal Cancer|Chemotherapy-induced Neutropenia
Interventions: DRUG: GM1|DRUG: placebo|DRUG: mFOLFOX6 or XELOX
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Trial to Learn About the Study Medicine (PF-07081532) and Rybelsus in People With Type 2 Diabetes and Separately PF-07081532 in People With Obesity
Status: TERMINATED
Conditions: Diabetes Mellitus|Obesity
Interventions: DRUG: PF-07081532|OTHER: Placebo|DRUG: Rybelsus
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety of Tranexamic Acid in Reducing Blood Loss Myomectomy.
Status: UNKNOWN
Conditions: Myoma
Interventions: DRUG: women receiving tranexamic acid|DRUG: women receiving misoprostol
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: OTHER
Clinical trial: SMART Watch Facilitated Early Discharge in Patients Undergoing Transcatheter Aortic Valve Replacement
Status: RECRUITING
Conditions: Aortic Stenosis|Valvular Heart Disease|Transcatheter Aortic Valve Replacement
Interventions: DEVICE: HUAWEI watch
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Determine the Effect of Administering Periostat(R) Twice Daily on Patients With Acne Rosacea
Status: COMPLETED
Conditions: Acne Rosacea
Interventions: DRUG: doxycycline hyclate 20 mg twice daily
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: LifeWalker Upright Walker vs. Conventional Rollator Walker and Predicate Device
Status: COMPLETED
Conditions: Back Pain
Interventions: DEVICE: LifeWalker Upright|DEVICE: Predicate Device|DEVICE: Standard Rollator
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Effects of Multicomponent Training on Inflammation Parameters and Muscle Quality in Elderly Obese Woman
Status: UNKNOWN
Conditions: Aging Disorder|Obesity|Inflammation
Interventions: OTHER: Multicomponent Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: Safety and Tolerability of Inebilizumab, VIB4920, or the Combination in Highly Sensitized Candidates Awaiting Kidney Transplantation From a Deceased Donor
Status: WITHDRAWN
Conditions: Highly Sensitized Patients on Waiting List for Kidney Transplantation
Interventions: DRUG: Inebilizumab|DRUG: VIB4920|DRUG: Inebilzumab+VIB4920
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Pharmacokinetics Study of Asciminib in Subjects With Impaired Renal Function Compared to Matched Healthy Volunteers
Status: COMPLETED
Conditions: Renal Impairment
Interventions: DRUG: Asciminib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Status: COMPLETED
Conditions: Kidney Cancer|Head and Neck Cancer|Breast Cancer|Non-small Cell Lung Cancer|Colorectal Cancer|Pancreatic Cancer|Ovarian Cancer|Esophageal Cancer|Gliomas
Interventions: DRUG: 177Lu-J591
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study in Rheumatoid Arthritis With an Investigational Oral p38 MAP Kinase Inhibitor VX-702
Status: COMPLETED
Conditions: Rheumatoid Arthritis
Interventions: DRUG: VX-702
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Study to Obtain Volume Effect and Safety Data on 6 % Hydroxyethyl Starch 130/0.4 in Pediatric and Adult Patients Undergoing Major Elective Surgery
Status: COMPLETED
Conditions: Plasma Volume Substitution (Hypovolemia) Including Massive Hemorrhage
Interventions: DRUG: 1: Hydroxyethyl starch 130/0.4, 6 %
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of PSMA-based PET as an Imaging Biomarker in Prostate Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Advanced Prostate Cancer
Interventions: DRUG: Pelvic DCFPyL PET-MRI fusion or PET/MRI
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Subcutaneous Lidocaine For Cancer-Related Pain
Status: COMPLETED
Conditions: Cancer-related Pain
Interventions: DRUG: Lidocaine|DRUG: Placebo (D5W)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Copenhagen Infant Mental Health Project: Enhancing Parental Sensitivity and Attachment (CIMHP)
Status: ACTIVE_NOT_RECRUITING
Conditions: Infant Social Withdrawal|Maternal Postnatal Depression
Interventions: BEHAVIORAL: Circle of Security -Parenting|BEHAVIORAL: Care as Usual
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669)
Status: COMPLETED
Conditions: Androgenetic Alopecia|Male Pattern Baldness|Female Pattern Baldness
Interventions: BIOLOGICAL: Autologous cultured dermal and epidermal cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients II
Status: COMPLETED
Conditions: Pulmonary Fibrosis
Interventions: DRUG: placebo|DRUG: BIBF 1120
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: Surgical Treatment of Concurrent Cataract and Primary Pterygium
Status: UNKNOWN
Conditions: Pterygium|Cataract|Lenses, Intraocular
Interventions: PROCEDURE: combined pterygium and cataract operation|PROCEDURE: pterygium excision followed by cataract operation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: FMT Combined With Immune Checkpoint Inhibitor and TKI in the Treatment of CRC Patients With Advanced Stage
Status: UNKNOWN
Conditions: Colorectal Neoplasms Malignant
Interventions: DRUG: Fecal microbiota transplantation plus Sintilimab and Fruquintinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation
Status: COMPLETED
Conditions: Acute Myelogenous Leukemia|Graft Versus Host Disease|Acute Lymphoblastic Leukemia|Chronic Myelogenous Leukemia|Myelodysplastic Syndromes|Non-Hodgkin's Lymphoma|Hodgkin's Disease
Interventions: DRUG: sirolimus|DRUG: tacrolimus
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Anlotinib Combined With Platinum/Gemcitabine for First Line Treatment of Advanced Urothelial Carcinoma
Status: UNKNOWN
Conditions: Urothelial Carcinoma|Anlotinib|Urogenital Neoplasms|Cisplatin|Carboplatin|Gemcitabine|Antineoplastic Agents
Interventions: DRUG: Anlotinib|DRUG: Cisplatin|DRUG: Carboplatin|DRUG: Gemcitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Repair, Remodeling and Regeneration of the Bronchial Epithelium of COPD Patients
Status: COMPLETED
Conditions: Heathy Volunteers|Smokers|COPD
Interventions: OTHER: In vitro experiments on bronchial epithelial cells
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Ultrasound Guided Adductor Canal Block Versus Femoral Nerve Block for Quadriceps Strength and Fall-risk
Status: COMPLETED
Conditions: Quadriceps Muscle Weakness|Adductor Muscle Weakness|Fall Risk
Interventions: PROCEDURE: Ultrasound Guided Adductor Canal Block|PROCEDURE: Ultrasound Guided Femoral Nerve Block
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Clinical Study of Treating Type 2 Diabetic Nephropathy With Alfacalcidol and Irbesartan
Status: COMPLETED
Conditions: Type 2 Diabetic Nephropathy
Interventions: DRUG: Alfacalcidol|DRUG: Irbesartan
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Montpellier PROspective Cohort in Relapsing Remitting Multiple Sclerosis Using Imaging and Serologic
Status: RECRUITING
Conditions: Multiple Sclerosis
Interventions: OTHER: Magnetic Resonance Imaging|OTHER: Blood withdrawal|OTHER: Neuropsychological tests
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: Evaluation of Parenting Interventions to Decrease Family Risk for Child Maltreatment
Status: COMPLETED
Conditions: Child Abuse
Interventions: BEHAVIORAL: Parent-Child Interaction Therapy|BEHAVIORAL: Health and Safety|BEHAVIORAL: Early Relationships
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Low Intensity Extracorporeal Shock Wave Therapy for the Treatment of Erectile Dysfunction- 4 Arms
Status: UNKNOWN
Conditions: Erectile Dysfunction
Interventions: DEVICE: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)|DEVICE: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)|DEVICE: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)|DEVICE: Extracorporeal Shockwave Therapy Generator (Omnispec ED1000)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Metabolic Cost of Suspension Exercise Training (SET-UTH)
Status: COMPLETED
Conditions: Body Composition|Physical Fitness|Energy Expenditure|Resting Metabolic Rate
Interventions: BEHAVIORAL: TR-30|BEHAVIORAL: TR-45
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (INVESTIGATOR)|Primary Purpose: OTHER
Clinical trial: A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema
Status: UNKNOWN
Conditions: Eczema
Interventions: DRUG: Mucopolysaccharide Polysulfate Cream|DRUG: Mucopolysaccharide Polysulfate Cream and glucocorticoids
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Opioid Use, Storage, and Disposal Among Pediatric Patients After Surgery
Status: COMPLETED
Conditions: Tonsillitis|Sleep Disordered Breathing|Hernia|Hydrocele|Hypospadias|Undescended Testicle|Circumcision
Interventions: OTHER: Disposal Aid
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: A Study to Learn About Two or More Vaccines That Are Put Together as One Shot Against Infectious Lung Illnesses, Including COVID-19 and Respiratory Syncytial Virus (RSV).
Status: COMPLETED
Conditions: Healthy Participants
Interventions: BIOLOGICAL: Combination [RSVpreF+BNTb162b2]|BIOLOGICAL: Bivalent BNT162b2 (original/Omi BA.4/BA.5)|BIOLOGICAL: RSVpreF|BIOLOGICAL: QIV|BIOLOGICAL: Normal Saline Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Healthy Habits Program for High Cardiovascular Risk Patients: Randomized Controlled Clinical Trial
Status: COMPLETED
Conditions: Health Behavior|Motor Activity|Food Habits
Interventions: BEHAVIORAL: Cognitive Behavioral Therapy|BEHAVIORAL: Informational Workshop
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Interest of Virtual Reality to Prevent Cancer Patient Anxiety Before Chemotherapy or an Invasive Act
Status: COMPLETED
Conditions: Anxiety|Chemotherapy Effect|Breast Cancer|Head Cancer Neck
Interventions: BEHAVIORAL: Virtual reality exposure
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: The Effect of Using Desensitizers Containing S-PRG In Treatment Of Dentin Hypersensitivity Over 6 Months: A Randomized Clinical Trial
Status: NOT_YET_RECRUITING
Conditions: Dentin Hypersensitivity
Interventions: PROCEDURE: Tooth varnish (PRG Barrier Coat from Shofu)|PROCEDURE: Tooth varnish (Clinpro white varnish 3M)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase II Multi-center Pilot Study of Concurrent Temozolomide and Whole Brain Irradiation in Lung Cancer and Breast Cancer Patients With Brain Metastases
Status: UNKNOWN
Conditions: Lung Cancer and Breast Cancer Patients With Brain Metastases
Interventions: DRUG: temozolomide 100mg
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of S-8184 in Treatment of Locally Advanced, Metastatic, or Recurrent TCC of the Urothelium
Status: COMPLETED
Conditions: Urologic Neoplasms
Interventions: DRUG: S-8184 Paclitaxel Injectable Emulsion|DRUG: Experimental Arm: TOCOSOL Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Frequency Modulation in TENS on Habituation and Pain Threshold
Status: COMPLETED
Conditions: Transcutaneous Electrical Nerve Stimulation
Interventions: DEVICE: TENS: Randomized frequency modulation|DEVICE: TENS: Scan 6/6 of frequency modulation|DEVICE: TENS: Fixed frequency|DEVICE: Sham Stimulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Diet in Twin Pregnancy: the Wellness of Mother and Babies.
Status: RECRUITING
Conditions: Twin Pregnancy, Antepartum Condition or Complication|Gestational Diabetes|Gestational Hypertension|Intrahepatic Cholestasis of Pregnancy|Food Habits|Diet, Healthy
Interventions: DIETARY_SUPPLEMENT: Specific Diet
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Sodium Thiosulfate for Treatment of Calcinosis Associated With Juvenile and Adult Dermatomyositis
Status: COMPLETED
Conditions: Dermatomyositis|Idiopathic Inflammatory Myopathies
Interventions: DRUG: Sodium Thiosulfate
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT